Fate Therapeutics Inc

FATE

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001434316

SEC filings (opens in a new tab)

In the last 90 days, Fate Therapeutics Inc insiders filed 0 open-market purchases and 2 sales; 156 institutions reported holding it in 13F filings for Q2 2026, worth $193.2M in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Fate Therapeutics Inc changed between Q4 2025 and Q1 2026.

All holders in Q1 2026 All holders in Q4 2025

13F holders of FATE: Q4 2025 compared with Q1 2026
Measure	Q4 2025	Of which not filed for Q1 2026	Q1 2026	Change
Holders	146	1	158	+13
Shares	72.1M	8.97M	74.1M	+10.9M (+17.3%)
Value	$70.9M	$8.82M	$88.9M	+$26.8M (+43.1%)

1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (28)

Institutions that held Fate Therapeutics Inc at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to FATE in Q1 2026
Institution	Shares	Value	% of portfolio
Vanguard Capital Management LLC	4,192,063	$5.03M	0.00%
Vanguard Portfolio Management LLC	4,134,585	$4.96M	0.00%
Irenic Capital Management LP	878,055	$1.05M	0.10%
Vanguard Fiduciary Trust Co	653,761	$784.5K	0.00%
Headlands Technologies LLC	125,708	$150.8K	0.02%
Schulhoff & Co Inc	100,000	$120.0K	0.05%
Abel Hall, LLC	36,748	$44.1K	0.01%
Vanguard Global Advisers, LLC	30,767	$36.9K	0.00%
Merit Financial Group, LLC	17,759	$21.3K	0.00%
Tiaa-Cref Individual & Institutional Services, LLC	17,592	$21.1K	0.00%
Krilogy Financial LLC	13,611	$18.6K	0.00%
Buckingham Strategic Partners	15,221	$18.3K	0.00%
Integrated Wealth Concepts LLC	14,946	$17.9K	0.00%
Caerus Investment Advisors, LLC	14,569	$17.5K	0.01%
Brighton Jones LLC	14,437	$17.3K	0.00%
Two Sigma Securities, LLC	11,537	$13.8K	0.00%
Financial Engines Advisors L.L.C.	10,992	$13.2K	0.00%
Axq Capital, LP	10,706	$12.8K	0.00%
Owl Creek Wealth Partners LLC	4,190	$5.03K	0.00%
MAI Capital Management	1,567	$1.88K	0.00%
UBS Asset Management Americas Inc	815	$978	0.00%
SRS Capital Advisors, Inc.	765	$918	0.00%
Root Financial Partners, LLC	365	$438	0.00%
Wealth Preservation Advisors, LLC	309	$371	0.00%
Twin Peaks Wealth Advisors, LLC	200	$240	0.00%
Basecamp Wealth Advisors LLC	109	$131	0.00%
SJS Investment Consulting Inc.	65	$78	0.00%
Caitong International Asset Management Co., Ltd	1	$1	0.00%

Sold out (15)

Institutions that held Fate Therapeutics Inc at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of FATE in Q1 2026
Institution	Shares, Q4 2025	Value, Q4 2025
Vestal Point Capital, LP	1,725,000	$1.69M
Two Sigma Advisers, LP	1,651,700	$1.62M
Millennium Management LLC	522,617	$513.5K
Knott David M Jr	365,000	$358.6K
Schonfeld Strategic Advisors LLC	192,682	$189.3K
Shay Capital LLC	70,000	$68.8K
Nine Masts Capital Ltd	19,445	$19.1K
Tiaa Trust, National Association	17,592	$17.3K
Sagewood Asset Management LP	15,003	$14.7K
AlphaCore Capital LLC	12,689	$12.5K
HBK Sorce Advisory LLC	10,659	$12.2K
Amalgamated Bank	3,417	$3.00K
Optiver Holding B.V.	1,132	$1.11K
Clearstead Advisors, LLC	18	$18
Turning Point Benefit Group, Inc.	14	$13

Not filed for Q1 2026 yet (1)

Institutions that held Fate Therapeutics Inc at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding FATE in Q4 2025 that haven't filed for Q1 2026
Institution	Shares, Q4 2025	Value, Q4 2025
Vanguard Group Inc	8,971,347	$8.82M